Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37

BACKGROUND: Chronic hepatitis C virus (HCV) infection leads to life-threatening complications worldwide. Immunomodulation signals the response to virus clearance. The immune-suppressive molecule human leukocyte antigen-G (HLA-G) has been shown to function in inhibiting both innate and adaptive immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Shi-xiong, Ma, Jian-bo, Hu, Yao-ren, Hu, Ai-rong, Shen, Qiang, Gao, Guo-sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915332/
https://www.ncbi.nlm.nih.gov/pubmed/27112970
http://dx.doi.org/10.12659/MSM.895971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915332/
https://www.ncbi.nlm.nih.gov/pubmed/27112970
http://dx.doi.org/10.12659/MSM.895971

Ejemplares similares